The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Magnesium sulphate versus phenytoin for eclampsia
Open accessAbstract
BACKGROUND: Eclampsia, the occurrence of a seizure in association with pre-eclampsia, remains a rare but serious complication of pregnancy. A number of different anticonvulsants have been used to control eclamptic fits and to prevent further seizures. OBJECTIVES: The objective of this review was to assess the effects of magnesium sulphate compared with phenytoin when used for the care of women with eclampsia. Magnesium sulphate is compared with diazepam and with lytic cocktail in other Cochrane reviews. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2010). SELECTION CRITERIA: Randomised trials comparing magnesium sulphate (intravenous or intramuscular administration) with phenytoin for women with a clinical diagnosis of eclampsia. DATA COLLECTION AND ANALYSIS: Two review authors assessed trial quality and extracted data. MAIN RESULTS: We have included data from seven trials, involving 972 women. One large trial (775 women) was of good quality. Magnesium sulphate was associated with a substantial reduction in the recurrence of seizures, when compared to phenytoin (six trials, 972 women; risk ratio (RR) 0.34, 95% confidence interval (CI) 0.24 to 0.49). The trend in maternal mortality favours magnesium sulphate, but the difference does not reach statistical significance (three trials, 847 women; RR 0.50, 95% CI 0.24 to 1.05). There were reductions in the risk of pneumonia (one trial, RR 0.44, 95% CI 0.24 to 0.79), ventilation (one trial, RR 0.68, 95% CI 0.50 to 0.91) and admission to an intensive care unit (one trial, RR 0.67, 95% CI 0.50 to 0.89) associated with the use of magnesium sulphate rather than phenytoin.For the baby, magnesium sulphate was associated with fewer admissions to a special care baby unit (SCBU) (one trial, 518 babies; RR 0.73, 95% CI 0.58 to 0.91) and fewer babies who died or were in SCBU for more than seven days (one trial, 643 babies; RR 0.77, 95% CI 0.63 to 0.95) than phenytoin. There was no clear difference in perinatal deaths (two trials, 665 babies; (RR 0.85, 95% CI 0.67 to 1.09). AUTHORS' CONCLUSIONS: Magnesium sulphate, rather than phenytoin, for women with eclampsia reduces the risk ratio of recurrence of seizures, probably reduces the risk of maternal death, and improves outcome for the baby. Magnesium sulphate is the drug of choice for women with eclampsia. The use of phenytoin should be abandoned.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO analysis of causes of maternal death: a systematic review
Khan, K. S., Wojdyla, D., Say, L., Gülmezoglu, A. M., & Van Look, P. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68397-9 · Cited by 3,978
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Research works printed but not linked: 87
- Valadares Neto, 2000, Treatment of eclampsia: comparative study on the use of magnesium sulfate and phenytoin, Revista Brasileira de Ginecologia e Obstetricia, 22, 543, 10.1590/S0100-72032000000900002 · doi:10.1590/s0100-72032000000900002
- Duley, 1995, Magnesium and eclampsia, Lancet, 346, 1365, 10.1016/S0140-6736(95)92377-2 · DOI
- Duley, 1998, Magnesium sulphate in eclampsia, Lancet, 352, 67, 10.1016/S0140-6736(05)79550-7 · DOI
- Duley, 1996, Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial, British Journal of Obstetrics and Gynaecology, 103, 103, 10.1111/j.1471-0528.1996.tb09657.x · DOI
- Duley, 1996, Magnesium sulphate should be used for eclamptic fits, BMJ, 312, 639, 10.1136/bmj.312.7031.639 · doi:10.1136/bmj.312.7031.639
- Duley L Magnesium sulphate, diazepam or phenytoin for women with eclampsia: results of the Collaborative Eclampsia Trial Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7; Dublin, 1995:32
- The Eclampsia Trial Collaborative Group, 1995, Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial, Lancet, 345, 1455, 10.1016/S0140-6736(95)91034-4 · DOI · Paper page
- Sawhney, 1999, Efficacy of magnesium sulphate and phenytoin in the management of eclampsia, Journal of Obstetrics and Gynaecology Research, 25, 333, 10.1111/j.1447-0756.1999.tb01172.x · doi:10.1111/j.1447-0756.1999.tb01172.x
- Dommisse, 1990, Phenytoin sodium and magnesium sulphate in the management of eclampsia, British Journal of Obstetrics and Gynaecology, 97, 104, 10.1111/j.1471-0528.1990.tb01734.x · doi:10.1111/j.1471-0528.1990.tb01734.x
- Naidu, 1996, Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound, British Journal of Obstetrics and Gynaecology, 103, 111, 10.1111/j.1471-0528.1996.tb09660.x · doi:10.1111/j.1471-0528.1996.tb09660.x
- Payne AJ Naidu S Moodley J Hoffmann M Gouws E Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial doppler ultrasound Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7; Dublin, Ireland 1995 302
- Friedman, 1993, Phenytoin versus magnesium sulphate in pre-eclampsia: a pilot study, American Journal of Perinatology, 10, 233, 10.1055/s-2007-994727 · doi:10.1055/s-2007-994727
- Friedman SA Kee-Hak L Cathy A Baker BS Repke JT A comparison of phenytoin infusion vs magnesium sulfate infusion in preeclampsia Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 Jan 23-27; Houston, Texas, USA 1990 16
- Friedman, 1995, Phenytoin versus magnesium sulfate in patients with eclampsia: preliminary results from a randomized trial, American Journal of Obstetrics and Gynecology, 172, 384, 10.1016/0002-9378(95)91142-1 · doi:10.1016/0002-9378(95)91142-1
- Chatterjee, 1997, Comparative study of different anticonvulsants in eclampsia, Journal of Obstetrics and Gynaecology Research, 23, 289, 10.1111/j.1447-0756.1997.tb00847.x · doi:10.1111/j.1447-0756.1997.tb00847.x
- Chatterjee, 1994, Comparative study of anticonvulsants in eclampsia, International Journal of Gynecology & Obstetrics, 46, 121
- Hangarga, 2001, A comparative study of phenytoin sodium with magnesium sulphate and Menon's regime in the treatment of eclampsia, Journal of Obstetrics and Gynecology of India, 51, 68
- Appleton, 1991, Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension, American Journal of Obstetrics and Gynecology, 65, 907, 10.1016/0002-9378(91)90437-V · doi:10.1016/0002-9378(91)90437-v
- Aaserud, 2005, Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia, BMC Health Services Research, 5, 68, 10.1186/1472-6963-5-68 · DOI
- Abalos, 2007, Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002252.pub2 · DOI · Paper page
- Ananth, 1995, Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991, Acta Obstetricia et Gynecologica Scandinavica, 74, 788, 10.3109/00016349509021198 · DOI
- Andersgaard, 2006, Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases, Acta Obstetricia et Gynecologica Scandinavica, 85, 929, 10.1080/00016340600607149 · doi:10.1080/00016340600607149
- Belfort, 1992, Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study, American Journal of Obstetrics and Gynecology, 167, 661, 10.1016/S0002-9378(11)91567-1 · DOI · Paper page
- Churchill, 2002, Interventionist versus expectant care for severe pre-eclampsia before term, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003106 · DOI
- Coyaji, 1990, Single high dose of intravenous phenytoin sodium for the treatment of eclampsia, Acta Obstetricia et Gynecologica Scandinavica, 69, 115, 10.3109/00016349009006154 · DOI
- Dinsdale, 1988, Does magnesium sulfate treat eclamptic seizures? Yes, Archives of Neurology, 45, 1360, 10.1001/archneur.1988.00520360078016 · doi:10.1001/archneur.1988.00520360078016
- Douglas, 1994, Eclampsia in the United Kingdom, BMJ, 309, 1395, 10.1136/bmj.309.6966.1395 · DOI · Paper page
- Duley, 1992, Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean, British Journal of Obstetrics and Gynaecology, 99, 547, 10.1111/j.1471-0528.1992.tb13818.x · DOI · Paper page
- Duley, 1996, The Collaborative Eclampsia Trial: which anticonvulsant for women with eclampsia [thesis]
- Duley, 1999, Plasma volume expansion for treatment of women with pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001805 · DOI
- Duley, 2000, Magnesium sulphate versus lytic cocktail for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002960 · DOI
- Duley, 2002, Drugs for treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002960 · DOI
- Duley, 2003, Magnesium sulphate versus diazepam for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000127 · DOI
- Duley, 2003, Magnesium sulphate and other anticonvulsants for women with pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000025 · DOI · Paper page
- Duley, 2005, Altered dietary salt for preventing pre-eclampsia, and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005548 · DOI
- Duley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004659.pub2 · DOI · Paper page
- Duley, 2008, Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007388 · doi:10.1002/14651858.cd007388
- Duley, 2009, Interventions for treating pre-eclampsia and its consequences: generic protocol, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007756 · DOI
- Eastman, 1945, The management of pre-eclampsia, Canadian Medical Association Journal, 52, 562
- Euser, 2009, Magnesium sulfate for the treatment of eclampsia: a brief review, Stroke, 40, 1169, 10.1161/STROKEAHA.108.527788 · DOI · Paper page
- Frias, 2003, Post Magpie: how should we be managing severe preeclampsia?, Current Opinion in Obstetrics and Gynecology, 15, 489, 10.1097/00001703-200312000-00006 · DOI
- Friedman, 1993, Phenytoin versus magnesium sulfate in preeclampsia: a pilot study, American Journal of Perinatology, 10, 233, 10.1055/s-2007-994727 · doi:10.1055/s-2007-994727
- Goldman RS Finkbeiner SM Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure New England Journal of Medicine 1988 1224 5 · doi:10.1056/nejm198811033191813
- Gülmezoglu, 1998, Use of anticonvulsants for eclampsia and pre-eclampsia: a survey of obstetricians in the United Kingdom and Republic of Ireland, BMJ, 316, 975, 10.1136/bmj.316.7136.975 · doi:10.1136/bmj.316.7136.975
- Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org · DOI · Paper page
- Hofmeyr, 2007, Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary, BJOG : an international journal of obstetrics and gynaecology, 114, 933, 10.1111/j.1471-0528.2007.01389.x · DOI · Paper page
- Igberase, 2006, Eclampsia: ten years of experience in a rural tertiary hospital in the Niger delta, Nigeria, Journal of Obstetrics and Gynaecology, 26, 414, 10.1080/01443610600720113 · DOI
- Katz, 2000, Preeclampsia into eclampsia: toward a new paradigm, American Journal of Obstetrics and Gynecology, 182, 1389, 10.1067/mob.2000.106178 · doi:10.1067/mob.2000.106178
- Knight, 2007, Eclampsia in the United Kingdom 2005, BJOG: an international journal of obstetrics and gynaecology, 114, 1072, 10.1111/j.1471-0528.2007.01423.x · DOI · Paper page
- Kullberg, 2002, Eclampsia in Sweden, Hypertension in Pregnancy, 21, 13, 10.1081/PRG-120002906 · DOI
- Langer, 2008, Reducing eclampsia-related deaths--a call to action, Lancet, 371, 705, 10.1016/S0140-6736(08)60321-9 · DOI
- Lewis, 2007, The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom
- Lumbiganon, 2007, Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be, Bulletin of the World Health Organization, 85, 763, 10.2471/BLT.06.037911 · DOI
- Altman, 2002, Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial, Lancet, 359, 1877, 10.1016/S0140-6736(02)08778-0 · DOI · Paper page
- Mahomed, 2007, Zinc supplementation for improving pregnancy and infant outcome, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000230.pub3 · DOI
- Makrides, 2001, Magnesium supplementation in pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000937 · DOI
- Makrides, 2006, Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003402.pub2 · DOI · Paper page
- McNamara, 2006, Pharmacotherapy of the epilepsies
- Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling, Health Technology Assessment, 12, iii-iv, 1-270, 10.3310/hta12060 · DOI · Paper page
- Meher, 2005, Interventions for preventing pre-eclampsia and its consequences: generic protocol, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005301 · DOI
- Meher, 2006, Exercise or other physical activity for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005942 · DOI
- Meher, 2007, Nitric oxide for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006490 · DOI
- Milne, 2005, The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community, BMJ, 330, 576, 10.1136/bmj.330.7491.576 · DOI · Paper page
- Chang, 2003, Pregnancy-related mortality surveillance--United States, 1991-1999, MMWR. Surveillance Summaries, 52, 1
- Naidu, 1992, The efficacy of phenytoin in relation to serum levels in severe pre-eclampsia and eclampsia, British Journal of Obstetrics and Gynaecology, 99, 881, 10.1111/j.1471-0528.1992.tb14434.x · doi:10.1111/j.1471-0528.1992.tb14434.x
- Neilson, 1995, Magnesium sulphate: the drug of choice in eclampsia, BMJ (Clinical research ed.), 311, 702
- Anonymous, 2000, Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, American Journal of Obstetrics and Gynecology, 183, S1, 10.1067/mob.2000.107928 · DOI · Paper page
- National Institute for Health and Clinical Excellence, 2008, Antenatal care
- Onuh, 2004, Maternal and fetal outcome in eclamptic patients in Benin City, Nigeria, Journal of Obstetrics and Gynaecology, 24, 765, 10.1080/01443610400009451 · DOI
- Pritchard, 1955, The use of the magnesium ion in the management of eclamptogenic toxemias, Surgery, Gynecology and Obstetrics, 100, 131
- Tuffnell, 2006, The management of severe pre-eclampsia/eclampsia. Greentop Guidelines (10A)
- Redman, 1984, Hypertension in pregnancy, 141
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008
- Roberts, 2002, Preventing and treating eclamptic seizures, BMJ (Clinical research ed.), 325, 609
- Roberts, 2005, Hypertensive disorders in pregnancy: a population-based study, Medical Journal of Australia, 182, 332, 10.5694/j.1326-5377.2005.tb06730.x · DOI · Paper page
- Robson, 1996, Magnesium sulphate: the time of reckoning, British Journal of Obstetrics and Gynaecology, 103, 99, 10.1111/j.1471-0528.1996.tb09656.x · doi:10.1111/j.1471-0528.1996.tb09656.x
- Rumbold, 2008, Antioxidants for preventing pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004227.pub3 · DOI · Paper page
- Sadeh, 1989, Action of magnesium sulfate in the treatment of preeclampsia-eclampsia, Stroke, 20, 1273, 10.1161/01.STR.20.9.1273 · doi:10.1161/01.str.20.9.1273
- Sevene, 2005, System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe, BMJ, 331, 765, 10.1136/bmj.331.7519.765 · DOI
- Sheth, 2002, Magnesium for preventing and treating eclampsia: time for international action, Lancet, 359, 1872, 10.1016/S0140-6736(02)08783-4 · DOI
- Sibai, 2005, Diagnosis, prevention, and management of eclampsia, Obstetrics & Gynecology, 105, 402, 10.1097/01.AOG.0000152351.13671.99 · DOI · Paper page
- Slater, 1987, Phenytoin infusion in severe pre-eclampsia, Lancet, 1, 1417, 10.1016/S0140-6736(87)90603-9 · DOI
- Villar, 2003, Eclampsia and pre-eclampsia: a health problem for 2000 years, 189
- World Health Organization, 1988, Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy, American Journal of Obstetrics and Gynecology, 158, 80
- World Health Organization, 2006, Pregnancy, childbirth, postpartum and newborn care - A guide for essential practice
- Zuspan, 1978, Problems encountered in the treatment of pregnancy-induced hypertension. A point of view, American Journal of Obstetrics and Gynecology, 131, 591, 10.1016/0002-9378(78)90816-5 · DOI
- Duley, 2003, Magnesium sulphate versus phenytoin for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000128 · DOI
Cited by
Global causes of maternal death: a WHO systematic analysis
Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.-B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70227-x · Cited by 6,582
Self-citationThe Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
Self-citationMagnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Renfrew, M. J., McFadden, A., Bastos, M. H., Campbell, J., Channon, A. A., Cheung, N. F., Silva, D. R. A. D., Downe, S., Kennedy, H. P., Malata, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60789-3 · Cited by 1,297
Metadata
- Authors
- Duley, L., Henderson-Smart, D. J., & Chou, D.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-10-06
- Volume
- 2010
- Issue
- 10
- Pages
- CD000128-CD000128
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1881403692
- Cited by
- 246
- References
- 2
- FWCI
- 31.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Magnesium sulphate versus phenytoin for eclampsia. https://app.cochat.ai/papers/10.1002/14651858.cd000128.pub2
- The paper
- Duley, L., Henderson-Smart, D. J., & Chou, D. (2010). Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000128.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.